youtube_live
Q3 2026 earnings • released • EPS beat +20.00% • Revenue beat +2.98%
See resultschevron_right
RXO:NYSE
RXO Inc
$27.82
arrow_upward
+1.20%(+0.33) 1D
$27.82
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:03 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RXO...
Open
$27.69
High
$27.90
Low
$27.48
Mkt. cap
4.59B
Avg. vol.
3.98M
Volume
2.02M
52-wk high
$29.90
52-wk low
$10.42
EPS
-$0.52
Beta
1.98
Shares outstanding
164.95M
No. of employees
7K
Open
$27.69
High
$27.90
Low
$27.48
Mkt. cap
4.59B
Avg. vol.
3.98M
Volume
2.02M
52-wk high
$29.90
52-wk low
$10.42
EPS
-$0.52
Beta
1.98
Shares outstanding
164.95M
No. of employees
7K
News stories
From web sources and news partners
The Motley Fool
·
6 hours ago
This Has Been the Best-Performing Stock in the "Magnificent Seven" This Year, and It's Not Even Close
BigGo Finance
·
1 hour ago
U.S. Midterm Elections Kick Off; Historical Data Shows S&P 500 Averaged Nearly 14% Gain in Year After Vote
investingLive
·
1 hour ago
JPMorgan’s four midterm scenarios: S&P 500 seen moving between -0.25% and +1.25%
Traders Union
·
4 hours ago
JOJO.Index outperformed long Treasuries with 6.26% return in August 2024, Michael A. Gayed notes
About RXO Inc
CEO-
Employees6.91K
Founded2022
HeadquartersCharlotte, North Carolina, United States
SectorIndustry
Websiterxo.com
Analyst ratings
Based on 13 analysts giving stock ratings to RXO in the past 3 months
Buy
Buy
4
Hold
9
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for RXO in the last 3 months.
Highest
Current $27.82
$33.00 (+18.62%)
Average
$29.88 (+7.40%)
Lowest
$27.00 (-2.95%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Christopher Stathoulopoulos Susquehanna | Hold | Maintained | $30.00 | +7.8% | 11/02/2026 |
Brandon Oglenski Barclays | Buy | Maintained | $28.00 | +0.6% | 11/02/2026 |
J. Bruce Chan Stifel Nicolaus | Buy | Maintained | $33.00 | +18.6% | 10/08/2026 |
Lucas Servera Truist Financial | Buy | Maintained | $30.00 | +7.8% | 10/07/2026 |
Ariel Rosa Citi | Hold | Maintained | $30.00 | +7.8% | 10/06/2026 |
Christian Wetherbee Wells Fargo | Hold | Maintained | $30.00 | +7.8% | 10/06/2026 |
Fadi Chamoun BMO Capital | Hold | Downgraded | $30.25 | +8.7% | 10/06/2026 |
Stephanie Moore Jefferies | Hold | Downgraded | $30.00 | +7.8% | 10/05/2026 |
Jason Seidl TD Cowen | Hold | Upgraded | $30.25 | +8.7% | 10/06/2026 |
Brian Ossenbeck J.P. Morgan | Hold | Upgraded | $30.00 | +7.8% | 10/06/2026 |
Thomas Wadewitz UBS | Hold | Maintained | - | - | 10/02/2026 |
Harrison Bauer Susquehanna | Hold | Upgraded | $19.00 | -31.7% | 09/23/2026 |
Ken Hoexter Bank of America Securities | Hold | Reiterated | $27.00 | -2.9% | 09/10/2026 |
Jeff Kauffman Citizens JMP | Buy | Upgraded | $30.00 | +7.8% | 08/07/2026 |
Jordan Alliger Goldman Sachs | Hold | Maintained | $20.00 | -28.1% | 07/16/2026 |
Unknown Analyst Citizens JMP | Hold | Initiated | - | - | 07/15/2026 |
Reed Seay Stephens | Hold | Initiated | $25.00 | -10.1% | 07/08/2026 |
Bascome Majors Stephens | Hold | Initiated | $25.00 | -10.1% | 07/08/2026 |
Unknown Analyst Raymond James | Hold | Maintained | - | - | 07/02/2026 |
Ravi Shanker Morgan Stanley | Hold | Downgraded | $22.00 | -20.9% | 05/08/2026 |
Last report
Oct 29, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.09 / $0.08
+20.00%beat
arrow_upward
Revenue / Est. (USD)
1.87B / 1.82B
+2.98%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 1.47B | 1.42B | 1.77B | 1.87B |
Cost of goods sold | 1.25B | 1.22B | 1.52B | 1.60B |
Cost of revenue | 1.25B | 1.22B | 1.52B | 1.60B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 200.00M | 197.00M | 211.00M | 223.00M |
Operating expense | 228.00M | 223.00M | 237.00M | 251.00M |
Total operating expenses | 1.48B | 1.44B | 1.76B | 1.85B |
Operating income | -9.00M | -19.00M | 12.00M | 24.00M |
Other non operating income | - | -3.00M | - | -1.00M |
EBT including unusual items | -51.00M | -49.00M | -8.00M | 6.00M |
EBT excluding unusual items | -18.00M | -31.00M | 3.00M | 13.00M |
Income tax expense | -5.00M | -13.00M | 1.00M | 3.00M |
Effective tax rate | 9.80% | 26.53% | -12.50% | - |
Other operating expenses | - | - | - | - |
Net income | -46.00M | -36.00M | -9.00M | 3.00M |
Net profit margin | -3.13% | -2.53% | -0.51% | 0.16% |
Earnings per share | -0.07 | -0.09 | 0.06 | 0.09 |
Interest and investment income | - | - | - | - |
Interest expense | -9.00M | -9.00M | -9.00M | -10.00M |
Net interest expenses | -9.00M | -9.00M | -9.00M | -10.00M |
Depreciation and amortization charges | 28.00M | 26.00M | 26.00M | 28.00M |
EBITDA | 19.00M | 7.00M | 38.00M | 52.00M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events